Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effectiveness of Mirtazapine in Patients with Acute Anxiety
KCT0008183Phase 4Recruiting
- Sponsor
- Hyundai Pharmaceutical Co., Ltd.
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of mirtazapine in major depressive disorder (MDD), anxiety disorder, sponsored by Hyundai Pharmaceutical Co., Ltd.. Started Jan 2023; status: recruiting.
02
Drugs
mirtazapine
03
Conditions
major depressive disorder (MDD)anxiety disorder
Beyond the preview
Go deeper on KCT0008183.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0008183.